Corrigendum to "Risk factors of first and recurrent genitourinary tract infection in patients with type 2 diabetes treated with SGLT2 inhibitors: a retrospective cohort study" [Diabetes Res. Clin. Pract. 186 (2022) 109816].

IF 6.1 3区医学 Q1 ENDOCRINOLOGY & METABOLISM

Diabetes research and clinical practice Pub Date : 2024-12-01 Epub Date: 2024-11-24 DOI:10.1016/j.diabres.2024.111925

Yi-Hsuan Lin, Chia-Hung Lin, Yu-Yao Huang, An-Shun Tai, Shih-Chen Fu, Szu-Tah Chen, Sheng-Hsuan Lin

引用次数: 0

查看原文本刊更多论文

对 "接受 SGLT2 抑制剂治疗的 2 型糖尿病患者首次和复发泌尿生殖道感染的风险因素：一项回顾性队列研究 "的更正 [Diabetes Res. Clin. Pract. 186 (2022) 109816]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Diabetes research and clinical practice 医学-内分泌学与代谢

CiteScore

10.30

自引率

3.90%

发文量

862

审稿时长

32 days

期刊介绍： Diabetes Research and Clinical Practice is an international journal for health-care providers and clinically oriented researchers that publishes high-quality original research articles and expert reviews in diabetes and related areas. The role of the journal is to provide a venue for dissemination of knowledge and discussion of topics related to diabetes clinical research and patient care. Topics of focus include translational science, genetics, immunology, nutrition, psychosocial research, epidemiology, prevention, socio-economic research, complications, new treatments, technologies and therapy.